Related Experiment Videos
[Six cases of allergic bronchopulmonary aspergillosis]
H Matsuse1, T Watanabe, C Fujiwara
1Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
Abstract:
Six cases of allergic bronchopulmonary aspergillosis (ABPA) were evaluated. In four cases, diagnosis and steroid therapy were delayed, which resulted in irreversible pulmonary dysfunction. The important points for early diagnosis were: (1) Differentiation from pulmonary tuberculosis, (2) the presence of bronchial asthma was not essential for diagnosis, and (3) fungi other than Aspergillus fumigatus might cause this syndrome.
Insights
Early diagnosis of allergic bronchopulmonary aspergillosis (ABPA) is crucial. Delayed diagnosis and treatment can lead to irreversible lung damage, highlighting the need for prompt identification and intervention.
Area of Science:
- Pulmonology
- Mycology
- Immunology
Background:
- Allergic bronchopulmonary aspergillosis (ABPA) is an inflammatory lung disease.
- It is often associated with Aspergillus fumigatus, but other fungi can be implicated.
- Prompt diagnosis is essential to prevent irreversible lung damage.
Observation:
- Six cases of ABPA were reviewed.
- Four cases experienced delayed diagnosis and steroid therapy.
- Delayed treatment led to irreversible pulmonary dysfunction in these patients.
Findings:
- Early ABPA diagnosis requires differentiating it from pulmonary tuberculosis.
- The presence of bronchial asthma is not a mandatory criterion for ABPA diagnosis.
- Fungal species beyond Aspergillus fumigatus can trigger ABPA.
Implications:
- Emphasizes the need for heightened clinical suspicion for ABPA, even without asthma.
- Highlights the importance of considering non-fumigatus Aspergillus species in ABPA.
- Underscores the critical impact of timely steroid therapy on preventing long-term pulmonary sequelae.